Eva Romanovsky

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

University Hospital Heidelberg(Current)

Heidelberg University

German Center for Lung Research

National Center for Tumor Diseases

German Cancer Research Center

Eva Romanovsky is an author at University Hospital Heidelberg specializing in immune checkpoint regulation, immunotherapy, and immune checkpoint inhibitor biomarkers.

ORCID

Publications per year

2024–2024

Publications

KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma

Jan Budczies, Eva Romanovsky, Martina Kirchner et al. · British Journal of Cancer · 2024 · 49 citations · Full text

Life Sciences, Immunology, Immunotherapy +16

Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world study

Gabriel Dernbach, Daniel Kazdal, Lukas Ruff et al. · European Journal of Cancer · 2024 · 11 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Benchmarking whole exome sequencing in the German network for personalized medicine

Michael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid et al. · European Journal of Cancer · 2024 · 11 citations · Full text

Medicine, Bioinformatics, Oncology +17

1–3 of 3